Cytek Biosciences Announces Closing of Its Initial Public Offering
FREMONT, Calif., July 27, 2021 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Cytek Biosciences or Cytek) (Nasdaq: CTKB), a leading cell analysis solutions company, announced today the closing of its initial public offering of an aggregate of 14,564,635 shares…
